Review Article
MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue
Table 1
Therapy with MnDPDP: cardioprotective adjunct to pPCI during AMI [25].
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are expressed as mean with values (two-tailed) included. Data in three rows to the right were obtained by the use of late Gd-enhancement MRI (gadopentetate dimeglumine). TIMI, grading of coronary flow from 0 to 3; STER, ST segment elevation regression at 48 hours; CK-MB, plasma creatine kinase isoenzyme MB 0–48 hours; LVEF: LV ejection fraction. |